Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Startglim MV 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Sanz Pharmaceuticals Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Startglim MV 2mg/500mg/0.2mg Tablet

Diabetic patients using the combined anti-diabetic medication, Glimepiride/Metformin/Pioglitazone 2mg/500mg/0.2mg tablets, should adhere to prescribed dosages. This medication manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage adjustments are determined by your physician based on your blood glucose levels. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control as directed by your healthcare provider. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them promptly. Maintain regular mealtimes and carry a fast-acting glucose source. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, bone fractures, and upper respiratory infections. Weight gain is possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, are recommended.

Uses of Startglim MV 2mg/500mg/0.2mg Tablet

Managing Type 2 Diabetes

Major Benefits of Startglim MV 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Startglim MV 2mg/500mg/0.2mg tablets should be administered on an empty stomach.

Common Side effects of Startglim MV 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Startglim MV 2mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Startglim MV 2mg/500mg/0.2mg Tablet whole; do not break, crush, or chew it. Administer on an empty stomach.

How Startglim MV 2mg/500mg/0.2mg Tablet works:

Each Startglim MV 2mg/500mg/0.2mg tablet contains a triple-action blend of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Startglim MV 2mg/500mg/0.2mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Startglim MV 2mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Startglim MV 2mg/500mg/0.2mg tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Startglim MV 2mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be forgone. Patients with severe kidney disease should definitely not use this medication. A physician's consultation is advised.

LiverLiverCAUTION

The use of Startglim MV 2mg/500mg/0.2mg tablets requires careful consideration in individuals with hepatic impairment. Dosage modifications for Startglim MV 2mg/500mg/0.2mg tablets may be necessary. Medical advice is recommended. In patients experiencing mild to moderate liver disease, Startglim MV 2mg/500mg/0.2mg tablets are typically initiated at a reduced dose; however, it's contraindicated in those with severe liver dysfunction.

What if you forget to take Startglim MV 2mg/500mg/0.2mg Tablet :

Should you forget to take your Startglim MV 2mg/500mg/0.2mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Startglim MV 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Startglim MV 2mg/500mg/0.2mg Tablet

Startglim MV combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This three-in-one tablet improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. It's not suitable for type 1 diabetes.
Startglim MV 2mg/500mg/0.2mg Tablets may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste perception, gas, stomach pain, headache, rash, and respiratory infections.
Startglim MV 2mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any component or excipient. Avoid use in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Startglim MV 2mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Startglim MV 2mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Startglim MV 2mg/500mg/0....
128
MRP 149
13% off